• Tidak ada hasil yang ditemukan

Lina Nasser AL-Tamimi Personal Information

N/A
N/A
Protected

Academic year: 2024

Membagikan "Lina Nasser AL-Tamimi Personal Information"

Copied!
4
0
0

Teks penuh

(1)

Lina Nasser AL-Tamimi

Personal Information

Mobile: +962795704288 Email: [email protected]

Address: Em Al-Summaq, Amman, Jordan Date of birth: 15th Dec 1977

Nationality: Jordanian and Turkish Marital Status: Married

Skills

Work

Microsoft office Teamwork Organization Problem-solving Time management Leadership

Planning skills Management skills Risk management

Modern learning methods Academic teaching Online learning Health care skills Dealing with patient Customer service Dealing with student

Profile

Ph.D. of Clinical Nutripharmacy and Supplementary Therapy with 8 years of experience as an academic instructor, 3 years of experience in a drug store, 3 years as a pharmacist in pharmacy with high skills in patients service, seeking for development, looking for new things to expand my horizons and develop my experience.

Experience

Assistant Professor

March 2022- Present Zarqa University- Faculty of Pharmacy- Clinical Pharmacy Department – Zarqa, Jordan

Academic Instructor (Lecturer) and Research Assistant

2014 – Feb 2022 University of Petra- Faculty of Pharmacy and Medical Sciences- Department of Medicinal Chemistry and Pharmacognosy – Amman, Jordan

Registration Officer & Consultant

2005 - 2008 UNION Drug Store - Amman, Jordan

Consultant Pharmacist

Seraa’ Pharmacy - Amman, Jordan 2001 - 2004 Nejmeh Pharmacy 2005-2006

Conferences

• Arab Health medical conference and exhibition 2004

2005

2006

2007

• Arab Lab medical conference and exhibition 2009

• ASU-Pharmacy First National Conference “Recent Trends in Postgraduate Research” 2014

• The 6th international Jordanian Congress of Allergy and Immunology, the 2nd pediatric Rheumatology Arab Group Meeting. Toward the best in allergy and immunology. The Jordanian Society of Allergy and Immunology 2017

(2)

Personal

Communication skills Self-motivated Creative thinking Persistent & ambitious Flexibility & Creativity

Languages

Arabic: Native (mother language) English: Very good (speaking, writing, and

reading)

References

Available upon request.

• The first international conference on pharmaceutical science (ICPS) 2019

• Faculty of Pharmacy seventh scientific day: Covid 19: outlooks and challenges – Zarqa university 2022

Training:

• Performance of preclinical efficacy, toxicity, and pharmacokinetic analysis, University of Petra Pharmaceutical Center (UOPPC) 2012

• Experiments in Pharmaceutical Dosage Model and Calculation Workshop, Continuing Education Center \ University of Petra 2014

• (MANAGING ACADEMIC PROGRAMS), Continuing Education Center \ University of Petra 2017

• Developing pharmacy curricula in Jordanian universities, University of Petra 2018

• Pharmacy Communication Skills Workshop, Continuing Education Center \ University of Petra 2021

Consultancy Work

Pharmacy Practice Exam for graduates of the non-Jordanian universities committee member: March, 2022

July, 2022

Reviewer at Jordan Journal of Pharmaceutical Sciences (JJPS), 2022

Education

Ph.D. Degree

University of Jordan- Amman, Jordan Grade: Excellent | GPA: 3.94/4 Sep 2017- Aug 2021

Master's Degree in Pharmacy & Pharmaceutical Sciences University of Petra – Faculty of Pharmacy - Amman, Jordan

Grade: Excellent | GPA: 3.81/4 Feb 2011- June 2014

Bachelor's Degree in Pharmacy

Applied Sciences University - Faculty of Pharmacy – Amman, Jordan Feb 1996 – June 2000

(3)

National High School – Jordan Umama High School - Amman, Jordan

June 1995

Projects of Thesis and Dissertation

Ph.D. Dissertation title:

Comparing the Effects of Chromium Picolinate, Chromium Glucose Tolerance Factor, and Pioglitazone, and their Combinations on

Chromium, Leptin, Peroxisome Proliferator-Activated Receptor Gamma, Insulin Resistance, Lipid Profile, Inflammatory Status, and Total

Antioxidant Capacity in Streptozotocin-Induced Type 2 Diabetic Rats Master thesis title:

Method Development, Validation, and Determination of Pioglitazone HCl with Sucralose in Rats Serum by Using High-Performance Liquid

Chromatography (HPLC/ UV)

Researches

• Spectrophotometric analysis of empagliflozin tablets as SGLT2 inhibitors in pharmaceutical samples (2022)

• Antidiabetic effect of aqueous extract of orthosiphon stamineus benth on alloxan -induced diabetic rats (2022)

• Development and validation of a stability-indicating HPLC-DAD method for the determination of canagliflozin and metformin simultaneously in combination dosage form (2021).

• Clinical nutrition in diabetes mellitus with third-degree burns and foot ulcers as complicated (2021)

• Fructose-Induced Insulin Resistance: Prospective Biochemical Mechanisms (2021)

• End-stage renal disease hemodialysis patient’s malnutrition treatment using intradialytic parenteral nutrition (IDPN);

prospective effectiveness and potential adverse effects (2021)

• Hepatic uptake, storage, and release of vitamin a in humans (2020)

• Folic acid bioavailability: a review (2020)

• Effect of smoking and obesity on the serum levels of vitamin d3 in the central region of Jordan (2019).

• Stability indicating of gemigliptin simultaneously estimation in its degradation product in market by RP-HPLC method (2018).

• Validation and determination of piracetam in rat plasma by using high performance liquid chromatography/UV/Vis spectrometry (HPLC/UV/vis) in presence of pomegranate and Liqourice juices for pharmacokinetic study (2017).

(4)

• Saxagliptin levels and its pharmacokinetic application in presence of sucralose in animals’ serum by HPLC method (2015)

• Simultaneous determination of atorvastatin, glimepiride, and amlodipine in solution and plasma matrix using HPLC/UV method (2014).

• Pioglitazone HCl levels and its pharmacokinetic application in presence of sucralose in animals’ serum by HPLC method (2014)

Referensi

Dokumen terkait